Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Almac Group
Almac Group
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Mewar Polytex launches non-woven disposable protective wear line
Mewar Polytex has launched its Dispowear line of non-woven disposable protective wear for hospitals, pharmaceuticals, chemicals, food processing, and cleanroom environments
Pfizer wins 2024 ISPE FOYA award with "central pool concept" API facility design
Pfizer has won the Operations, Project Execution category at 2024's ISPE Facility of the Year Awards. Purtias Asgard completed work as the cleanroom subcontractor for this...
TSMC comments on cleanroom evacuation
Cleanroom Technology reached out to TSMC to see how the recent magnitude 4 earthquakes had impacted semiconductor production operations
Envair and Total Containment Solutions re-brand to become Envair Technology
Envair and TCS are now operating under one logo and name, Envair Technology
Identifying and preventing contaminant leakage from your cleanroom
A common solution to machinery contamination in a cleanroom is to build a cleanroom within a cleanroom using partitions or curtains, to isolate the machine. Chris Lindlar from...
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Manufacturing
Almac Group launches new addition to temperature management service
Tempod 1000 has been created to improve clinical site temperature data management as manual methods of data capture have proved challenging due to disruptions caused by the global pandemic
Almac Discover appoints new VP of BD & Licensing
Dr Alan Lamont will report to Managing Director & President, Dr Stephen Barr
Manufacturing
Almac Group appoints Dr Sheryl Foster as Vice President of Quality
Estates & Facilities
Almac Group extends personalised cancer vaccine production facilities
The pharmaceutical CDMO will be investing in new labs and office spaces
Pharmaceutical
Galen appoints Dr Dennise Broderick as Managing Director
Manufacturing
Almac Group launches second line for high throughput GMP Peptide
Based in Edinburgh, Scotland, the facility manufactures neoantigen derived peptides for use in the production of patient specific, individualised cancer vaccines
Regulatory
Almac passes HSA inspection of Asia Pacific operation
The British CDMO has received renewal of the GMP/GDP certification of its Singapore facility from the Health Sciences Authority
Subscribe now